Searched for
DR VISHAL RAO
Bengaluru's second patient treated with plasma therapy recoversThe city reported the first case of recovery of a Covid-19 patient who was administered convalescent plasma therapy at Victoria Hospital.
Karnataka hospital starts plasma therapy trials for Covid-19 patientsThe state medical education minister thanked the Covid-19 survivor who volunteered to donate his blood for the Covalescent Plasma Therapy (...
Bengaluru’s HCG hospital gets nod for plasma therapy clinical trialsThe Central Drugs Standard Control Organisation (CDSCO), under the health ministry, approved the proposal after the Indian Council of Medic...
ICMR nod to pvt hospital to try plasma therapy for COVID-19 patientsThis was stated by the Drugs Controller General of India in a letter to to HCG Bangalore Institute of Oncology Speciality Centre. The permi...
Covid-19: HCG team develops treatment protocol, writes to Drugs Controller GeneralA three-member team at HCG Hospital in Bengaluru has developed a treatment protocol for covid-19 positive patients.
COVID-19: HCG team's find offers hope for treatmentA three-member team at HCG Hospital in Bengaluru has developed a treatment protocol for Covid-19-positive patients. It is centred on inject...
Bengaluru traffic police vulnerable to lung-related diseases, says OncologistChronic infections are risk factors for lung cancer, reason being exposed to environmental pollution which comprises air and water pollutio...
Allow smoking, lose bar & eatery licence: BBMP to bars in BengaluruThe circular is hailed as a victory to the sustained campaign by antitobacco activists including oncologist Dr Vishal Rao, who is a member ...
- Buy Bliss GVS Pharma, target Rs 214: Kunal Bothra
Buy Bliss GVS Pharma Ltd. at a price target of Rs 214.0 and a stop loss at Rs 192 from entry point.
- Buy Infosys, target Rs 1008: Siddharth Bhamre
Buy Infosys Ltd. at a price target of Rs 1008 and a stop loss at Rs 918.0 from entry point
- Buy Infosys, target Rs 975.0 : Rahul Randeria
Buy Infosys Ltd. at a price target of Rs 975.0 and a stop loss at Rs 915.0 from entry point
- Buy Infosys, target Rs 944: Nirmal Bang Securities
Buy Infosys Ltd. at a price target of Rs 944.0 and a stop loss at Rs 908.0 from entry point
He quits again: Former Infosys CFO Rajiv Bansal now leaves OlaThe top level churn at Ola comes as the company also moved chief operating officer and first employee Pranay Jivrajka to an undefined role ...
Meet the doctors who understand the need of frugal startup innovation"It is imperative for doctors to be driving innovation in the medical devices space," says Dr Chaturvedi.
Infosys CEO Vishal Sikka rakes in $7.45 million in salary, other top executives also see jump in paySikka’s new salary structure is at par with CEOs of other global IT firms, including Cognizant, whose CEO Francisco D’Souza took home a nea...
Bengaluru doctor designs Rs 50 device to give patients their lost voice backThroat cancer patients who have lost their voice can look forward to speaking again, without having to shell out thousands on an artificial...
Meet Vishal Rao, an oncologist who tries to prevent tobacco addictionGrowing up in a family of doctors in Mangaluru, Dr Vishal Rao was taught to have a value-based approach to medicine.